US2022136044A1PendingUtilityA1
Methods, compositions, kits, and uses for analysis of nucleic acids comprising repeating a/t-rich segments
Est. expiryJul 23, 2035(~9 yrs left)· nominal 20-yr term from priority
C12Q 1/6844
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Described herein are methods, compositions, kits, and uses thereof for analysis of nucleic acid segments comprising a repeating A/T-rich segment, wherein the repeating A/T-rich segment is: (i) a homopolymeric segment comprising at least 10 A residues, at least 10 T residues, or at least 10 U residues, wherein the at least 10 A, T, or U residues are consecutive or interrupted once by one to three other nucleotides; or (ii) a segment comprising (TnA)m, (ATn)m, (TAn)m, or (AnT)m, wherein n is 2 or greater and m is such that the length of the repeating A/T-rich segment is 10 or more residues.
Claims
exact text as granted — not AI-modified1 - 73 . (canceled)
74 . A kit comprising:
at least two primers; and NTPs in an AT/GC ratio of 8 or higher,
wherein the at least two primers are capable of amplifying at least one DNA template comprising:
(i) a homopolymeric segment of at least 10 consecutive A residues or at least 10 consecutive T residues;
or (ii) a repeating A/T-rich segment comprising (T n A) m , (AT n ) m , (TA n ) m , or (A n T) m , wherein n is 2 or greater and m is such that the length of the repeating NT-rich segment is 10 or more residues;
wherein the at least one DNA template further comprises target and non-target nucleic acid sequences.
75 . The kit of claim 74 , wherein the at least two primers comprise at least one primer comprising a covalently attached label.
76 . The kit of claim 74 , wherein the at least two primers comprise a first primer that hybridizes upstream of the rs10524523 variable length polymorphism of the TOMM40 gene and a second primer that hybridizes downstream of the rs10524523 variable length polymorphism of the TOMM40 gene.
77 . The kit of claim 74 , wherein the kit further comprises at least one polymerase.
78 . The kit of claim 74 , wherein the AT/GC ratio is a value in the range from about 10 to about 40.
79 . The kit of claim 74 , wherein the NTPs comprise dNTPs or rNTPs, and are present in a total NTP concentration ranging from about 0.5 mM to about 5 mM.
80 . The kit of claim 74 , wherein dGTP is present in a concentration ranging from about 10 μM to about 400 μM and cytidine is present in a concentration ranging from about 10 μM to about 400 μM.
81 . The kit of claim 74 , wherein dTTP is present in a concentration ranging from about 700 μM to about 2000 μM and adenosine is present in a concentration ranging from about 700 μM to about 2000 μM.
82 . The kit of claim 74 further comprising Mg 2+ , wherein the Mg 2+ is present in a molarity ranging from about 80% to about 150% of the molarity of total NTPs.
83 . The kit of claim 74 further comprising Mg 2+ , wherein the Mg 2+ is present in a concentration ranging from about 1.5 mM to about 3 mM.
84 . The kit of claim 74 , wherein the at least one nucleic acid template comprises a homopolymeric segment comprising 10 to 40 consecutive A residues or 10 to 40 consecutive T residues.
85 . The kit of claim 74 , wherein the at least one nucleic acid template comprises a homopolymeric segment of at least 10 consecutive T residues.
86 . The kit of claim 74 , wherein the at least one nucleic acid template comprises a segment comprising (T n A) m , (AT n ) m , (TA n ) m , or (A n T) m , wherein n is 2 or greater and m is such that the length of the repeating A/T-rich segment is 10 or more residues.
87 . The kit of claim 74 , wherein at least one primer comprises a 3′-terminal sequence that specifically hybridizes to two or more consecutive A residues or to two or more consecutive T residues.
88 . The kit of claim 87 , wherein the at least one primer comprises a 3′-terminal sequence comprising 4 to 9 consecutive A residues or 4 to 9 consecutive T residues.
89 . The kit of claim 74 , wherein at least one primer comprises a covalently attached label.
90 . The kit of claim 77 , wherein the at least one polymerase comprises a hot-start DNA polymerase.
91 . The kit of claim 74 , wherein the at least one nucleic acid template comprises a homopolymeric segment comprising at least 12 consecutive A residues or at least 12 consecutive T residues.
92 . The kit of claim 74 wherein the at least one nucleic acid template comprises a homopolymeric segment in a genetic locus associated with late-onset Alzheimer's disease.
93 . The kit of claim 74 , wherein the at least one nucleic acid template comprises a subset of TOMM40 sequence comprising a homopolymeric segment of at least 10 consecutive T residues.Join the waitlist — get patent alerts
Track US2022136044A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.